Bmrn analyst rating
WebMar 22, 2024 · 1/30/2024 – BioMarin Pharmaceutical is now covered by analysts at BMO Capital Markets. They set a “market perform” rating and a $107.00 price target on the stock. 1/24/2024 – BioMarin ... WebMar 1, 2024 · BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN – Get Rating) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $119.00 ...
Bmrn analyst rating
Did you know?
WebApr 10, 2024 · Biomarin Pharmaceutical stock has received a consensus rating of buy. The average rating score is and is based on 27 buy ratings, 11 hold ratings, and 1 sell ratings. What was the... WebApr 9, 2024 · Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are …
WebApr 13, 2024 · One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company... WebApr 8, 2024 · In a report released on April 6, Luca Issi from RBC Capital maintained a Hold rating on BioMarin Pharmaceutical ( BMRN – Research Report ), with a price target of $100.00. The company’s shares ...
WebAnalyst Rating / Earnings Estimates. Current Rating See More. Moderate Buy. Based on 20 analysts offering recommendations. Earnings Estimates - Current Qtr 03/31/23 ... (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery,... BMRN: 98.05 (-1.56%) More news for this symbol. Barchart … WebAnalyst Ratings are available for US and Canadian equities. Unlike Barchart Opinions (which calculate the Buy/Sell rating using a variety of short-medium and long-term …
WebApr 10, 2024 · Biomarin Pharmaceutical stock has received a consensus rating of buy. The average rating score is and is based on 27 buy ratings, 11 hold ratings, and 1 sell …
WebApr 13, 2024 · According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $118.15. Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently modified their holdings of BMRN. inconel heat shield vs ceramicWebMar 21, 2024 · Where Biomarin Pharmaceutical Stands With Analysts - Biomarin Pharmaceutical (NASDAQ:BMRN) - Benzinga Español India Italiano Français My Account My Account Notifications Overview + New... incidence of cancer usWebApr 9, 2024 · Xponance Inc. grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Rating) by 81.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.The institutional investor owned 6,503 shares of the biotechnology company's stock after purchasing an additional … inconel hardwareWebOct 19, 2024 · BioMarin Pharmaceutical Inc. analyst estimates, including BMRN earnings per share estimates and analyst recommendations. inconel hardware wire meshWebApr 11, 2024 · BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) CEO Jean Jacques Bienaime sold 10,000 shares of the business’s stock in a transaction dated Thursday, April 6th. The shares were sold at ... inconel hex stockWebMar 7, 2024 · Bank of America Securities analyst Kevin Fischbeck maintained a Buy rating on UnitedHealth today and set a price target of $650.00. The company’s shares closed last Monday at $480.78. According... inconel heaterWebOut of 14 analysts, 5 ( 35.71%) are recommending BMRN as a Strong Buy, 3 ( 21.43%) are recommending BMRN as a Buy, 5 ( 35.71%) are recommending BMRN as a Hold, 1 ( 7.14%) are recommending BMRN as a Sell, and 0 ( 0%) are recommending BMRN as a Strong Sell. If you're new to stock investing, here's how to buy Biomarin … inconel hex nuts